InvestorsHub Logo
Followers 1
Posts 124
Boards Moderated 0
Alias Born 05/20/2016

Re: None

Tuesday, 12/27/2016 12:33:31 PM

Tuesday, December 27, 2016 12:33:31 PM

Post# of 468064
$3B is a lot given the history of Biogen's frugality when it comes to M&A expenditures. This website compared the value of M&As made by big pharma companies between 1994-2012. Biogen spent about $3B in total for its acquisitions. I would guess they may offer a max of $500- $750m given the level of risk...

They have got then best value per M&A dollar though..

https://biostrategyanalytics.com/2016/11/22/winners-and-losers-in-pharma-biotech-mergers-and-acquisitions-biogen-shines-again/